{"id":6328,"date":"2020-03-13T08:44:50","date_gmt":"2020-03-13T08:44:50","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/"},"modified":"2020-03-13T08:44:50","modified_gmt":"2020-03-13T08:44:50","slug":"realheart-utvecklingsplan-2020","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-utvecklingsplan-2020\/","title":{"rendered":"Realheart utvecklingsplan 2020"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Realheart st\u00e5r idag p\u00e5 en stabil grund tack vara en rad uppn\u00e5dda milstolpar som \u00e4gde rum under f\u00f6rra \u00e5ret. 2019 centrerades Realhearts verksamhet kring produktutveckling, laboratorietester och l\u00e5ngtidstester p\u00e5 djur. Bolaget kan konstatera att stora framsteg har gjorts inom alla tre omr\u00e5den och avslutade \u00e5ret med ett gynnsamt djurf\u00f6rs\u00f6k d\u00e4r f\u00e5ret \u00f6verlevde de f\u00f6rsta mest kritiska 20 timmarna, vilket markerar avslutet p\u00e5 l\u00e5ngtidsf\u00f6rs\u00f6kens f\u00f6rberedelsefas.<\/strong><\/div>\n<p><span><span><span><strong><span><span><span>Utvecklingsplan 2020 <\/span><\/span><\/span><\/strong><\/span><\/span><\/span><\/p>\n<p><span><span><span><span>De tre omr\u00e5den Realheart avser arbeta inom under 2020 \u00e4r: produktifiering, leverant\u00f6rs- och partnersamarbeten f\u00f6r tillverkning samt FDA:s kravspecifikation.<\/span><\/span><\/span><\/span><\/p>\n<p>\u00a0<\/p>\n<p><span><span><span><em><span><span><span>Produktifiering<\/span><\/span><\/span><\/em><\/span><\/span><\/span><\/p>\n<ul>\n<li><span><span><span><span><span><span>Optimera pumpens mekaniska egenskaper<\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span><span>Slutf\u00f6ra designarbetet f\u00f6r att m\u00f6ta produktionskrav<\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span><span>P\u00e5b\u00f6rja certifiering av bolaget enligt ISO 13485 f\u00f6r medicintekniska f\u00f6retag<\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<p><span><span><span><em><span><span><span>Leverant\u00f6rs- och partnersamarbeten f\u00f6r tillverkning<\/span><\/span><\/span><\/em><\/span><\/span><\/span><\/p>\n<ul>\n<li><span><span><span><span><span>Identifiera l\u00e4mpliga leverant\u00f6rer och partners med erfarenhet av tillverkning av h\u00f6gkvalitativa medicintekniska produkter <\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span>S\u00e4kerst\u00e4lla tillg\u00e5ng till de mest l\u00e4mpade leverant\u00f6rerna f\u00f6r samtliga kritiska komponenter<\/span><\/span><\/span><\/span><\/span><\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<p><span><span><span><em><span><span><span>FDA:s kravspecifikation<\/span><\/span><\/span><\/em><\/span><\/span><\/span><\/p>\n<ul>\n<li><span><span><span><span><span><span>Fortsatta djurstudier med fokus p\u00e5 l\u00e5ngtidsf\u00f6rs\u00f6k och att utveckla kirurgin<\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span><span>Genomf\u00f6ra blodtester och fl\u00f6destudier med hj\u00e4lp av datoriserade program och magnetkamera<\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<li><span><span><span><span><span><span>Fortsatta h\u00e5llbarhetstester <\/span><\/span><\/span><\/span><\/span><\/span><\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<p><span><span><span><span>\u201dJag \u00e4r mycket stolt \u00f6ver det arbete som utf\u00f6rts av teamet under 2019. Det har f\u00f6rberett Realheart v\u00e4l f\u00f6r 2020 och fram\u00e5t. \u00c4ven om det \u00e4r n\u00e5gra \u00e5r kvar tills Realheart TAH n\u00e5r marknaden konkretiseras v\u00e5rt arbete i allt h\u00f6gre takt. Det k\u00e4nner jag inte minst nu n\u00e4r vi nu b\u00f6rjar titta p\u00e5 produktionspartners\u201d, s\u00e4ger vd och grundare Azad Najar.<\/span><\/span><\/span><\/span><\/p>\n<p>\u00a0<\/p>\n<div class=\"mfn-footer\">\n<p><span><strong>F\u00f6r ytterligare information kontakta:<\/strong><\/span><\/p>\n<p><span>Azad Najar, VD <\/span><\/p>\n<p><span>Tel: +46(0)736-673\u00a0463<\/span><\/p>\n<p><span>E-post:\u00a0<\/span><a href=\"mailto:azad.najar@realheart.se\" rel=\"nofollow\"><span>azad.najar@realheart.se<\/span><\/a>\u00a0<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><span><em>Scandinavian Real Heart AB utvecklar ett komplett artificiellt hj\u00e4rta (Total Artificial Heart \u2013 TAH) f\u00f6r implantation i patienter med livshotande hj\u00e4rtsvikt. Bolagets TAH har en unik, patenterad, design som innefattar en kopiering av det naturliga m\u00e4nskliga hj\u00e4rtat. Real Hearts TAH inf\u00f6rlivar ett fyrkammarsystem (tv\u00e5 f\u00f6rmak, tv\u00e5 kamrar) vilket ger m\u00f6jlighet att generera ett fysiologiskt anpassat blodfl\u00f6de som efterliknar kroppens naturliga cirkulation. Ett koncept som \u00e4r unikt i den medicintekniska v\u00e4rlden. <\/em><em><\/em><\/span><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/release.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3058836%2F1210725.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/release.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3058836%2F1210725.pdf&type=jpg\"><\/span>Release<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Realheart st\u00e5r idag p\u00e5 en stabil grund tack vara en rad uppn\u00e5dda milstolpar som \u00e4gde rum under f\u00f6rra \u00e5ret. 2019 centrerades Realhearts verksamhet kring produktutveckling, laboratorietester och l\u00e5ngtidstester p\u00e5 djur. Bolaget kan konstatera att stora framsteg har gjorts inom alla tre omr\u00e5den och avslutade \u00e5ret med ett gynnsamt djurf\u00f6rs\u00f6k d\u00e4r f\u00e5ret \u00f6verlevde de f\u00f6rsta mest&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6328","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn-lang-sv"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Realheart utvecklingsplan 2020 - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Realheart utvecklingsplan 2020 - Realheart\" \/>\n<meta property=\"og:description\" content=\"Realheart st\u00e5r idag p\u00e5 en stabil grund tack vara en rad uppn\u00e5dda milstolpar som \u00e4gde rum under f\u00f6rra \u00e5ret. 2019 centrerades Realhearts verksamhet kring produktutveckling, laboratorietester och l\u00e5ngtidstester p\u00e5 djur. Bolaget kan konstatera att stora framsteg har gjorts inom alla tre omr\u00e5den och avslutade \u00e5ret med ett gynnsamt djurf\u00f6rs\u00f6k d\u00e4r f\u00e5ret \u00f6verlevde de f\u00f6rsta mest...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-utvecklingsplan-2020\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-utvecklingsplan-2020\\\/\",\"name\":\"Realheart utvecklingsplan 2020 - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2020-03-13T08:44:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-utvecklingsplan-2020\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-utvecklingsplan-2020\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/realheart-utvecklingsplan-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Realheart utvecklingsplan 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Realheart utvecklingsplan 2020 - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/","og_locale":"sv_SE","og_type":"article","og_title":"Realheart utvecklingsplan 2020 - Realheart","og_description":"Realheart st\u00e5r idag p\u00e5 en stabil grund tack vara en rad uppn\u00e5dda milstolpar som \u00e4gde rum under f\u00f6rra \u00e5ret. 2019 centrerades Realhearts verksamhet kring produktutveckling, laboratorietester och l\u00e5ngtidstester p\u00e5 djur. Bolaget kan konstatera att stora framsteg har gjorts inom alla tre omr\u00e5den och avslutade \u00e5ret med ett gynnsamt djurf\u00f6rs\u00f6k d\u00e4r f\u00e5ret \u00f6verlevde de f\u00f6rsta mest...","og_url":"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/","url":"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/","name":"Realheart utvecklingsplan 2020 - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2020-03-13T08:44:50+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/realheart-utvecklingsplan-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Realheart utvecklingsplan 2020"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}